Abbott Laboratories (NYSE:ABT) on Tuesday raised its full-year profit forecast after its financial results for the third quarter of 2024 beat Wall Street forecasts, driven mainly by strength in its Pharma and MedTech segments.

The North Chicago, Illinois-based medical device maker reported revenue of $10.6 billion.